Patients received Treatments ( A ) placebo/placebo , ( B ) canagliflozin @ mg/placebo , ( C ) canagliflozin @ mg/canagliflozin @ mg , or ( D ) canagliflozin @ mg/canagliflozin @ mg on Day @/Day @ in one of four treatment sequences ( similar urinary glucose excretion -LSB- UGE -RSB- expected for Treatments B-D ) .